CazOnReal wrote:Merit wrote:
You’re smoking too much herb. (No idea if you do, but yeah - this is obviously tongue in cheek). Now on to the real: If they can trade this year’s first for Derik Queen and trade for Jordan Poole I’m gonna have to agree to disagree. Heck they traded BI for a single first rounder.
IMO the only reason you’re saying what you’re saying is because Herb is on a value contract. You’re also underrating Gradey on a rookie scale and Battle as well. An argument can be made that NOP has too many middle of the road players on smaller contracts - but even then, they have the opportunity to aggregate and be a player in larger trades as well.
No idea if this happens, but I am comfortable with my valuation.
Ingram went for as cheap as he did because of his injury history, him being expiring/in need of a new contract to the team he was traded to and his flaws as a player i.e. his defense. See also: Us not getting any 1sts for O.G. from the Knicks for similar reasons.
Herb is on one of the better contracts in the league, he's on that contract for the next 4-ish years, is a decent 3-point shooter and is one of the best defenders in the league. Call the Mikal Bridges an overpay but guys like that tend to go for several firsts and teams are oft willing to bite on that overpay.
A second is not cutting it. Be serious.
The other ridiculous notion I've seen thrown around is to acquire Jones for our bench LOL. There is no world where Herb doesn't start for us, and about 27-28 other teams.
























